Cue Biopharma (CUE)
(Delayed Data from NSDQ)
$0.72 USD
+0.02 (3.00%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $0.72 0.00 (-0.14%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.22 | 8.05% |
Earnings Summary
For their last quarter, Cue Biopharma (CUE) reported earnings of -$0.20 per share, beating the Zacks Consensus Estimate of $-0.29 per share. This reflects a positive earnings surprise of 31.03%. Look out for CUE's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year increase of 8.33%.
Earnings History
Price & Consensus
Zacks News for CUE
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
CUE: What are Zacks experts saying now?
Zacks Private Portfolio Services